FDA approves treatment for people with mild forms of Alzheimer’s
Jaimy Lee The Food and Drug Administration on Friday granted accelerated approval to Eisai and Biogen's ...
Read moreJaimy Lee The Food and Drug Administration on Friday granted accelerated approval to Eisai and Biogen's ...
Read moreJan 7 (Reuters) - The U.S. Food and Drug Administration on Friday approved the Alzheimer's drug ...
Read moreWhy Are Alzheimer’s Stocks Up Today? This article discusses a handful of penny stocks with exposure ...
Read moreIn the depths of frigid, snowy Chicago winters, it’s wise and life-saving to wear plenty of ...
Read moreLongeveron (NASDAQ:LGVN) stock is taking off on Thursday after the drugmaker published news related to an ...
Read moreThe F.D.A. also required Biogen to conduct another clinical trial to determine if the drug provided ...
Read more© 2022 TheDailyStock.News